Histamine metabolites in cerebrospinal fluid of patients with chronic schizophrenia: their relationships to levels of other aminergic transmitters and ratings of symptoms
- 31 January 1995
- journal article
- Published by Elsevier in Schizophrenia Research
- Vol. 14 (2) , 93-104
- https://doi.org/10.1016/0920-9964(94)00034-6
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- The effects of morphine, morphine plus scopolamine, midazolam and promethazine on cerebrospinal fluid histamine concentration and postoperative analgesic consumptionInflammation Research, 1991
- Influence of age and gender on the levels of histamine metabolites and pros-methylimidazoleacetic acid in human cerebrospinal fluidArchives of Gerontology and Geriatrics, 1991
- FamotidineDrugs, 1989
- Diurnal fluctuation in levels of histamine metabolites in cerebrospinal fluid of rhesus monkeyInflammation Research, 1989
- Aspects of histamine metabolismInflammation Research, 1987
- Pharmacology of the novel H2 antagonist famotidine: In vitro studiesInflammation Research, 1986
- Regional differences in the turnover of neuronal histamine in the rat brainLife Sciences, 1984
- Histamine and histamine-N-methyltransferase in the CSF of patients with multiple sclerosisInflammation Research, 1983
- An improved GCMS method to measure tele-methylhistamineJournal of Pharmacological Methods, 1981
- 1,4-methylhistamine is a specific substrate for type B monoamine oxidaseLife Sciences, 1979